Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1248 |
|
| Actual shortage: | 54 (4%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 36 (3%) | |
| Resolved: | 1158 (93%) | |
Discontinuation Reports |
284 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 283 (100%) | |
| Reversed: | 1 (0%) | |
Late reports |
208 (14%) |
|
Overdue reports |
8 (15%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-ROPINIROLE | 0.25MG | TABLET | Resolved | 2020-03-27 | 2020-06-09 | 109694 |
| PMS-ROPINIROLE | 2.0MG | TABLET | Resolved | 2020-03-27 | 2020-06-09 | 109712 |
| PMS-ROSUVASTATIN | 10MG | TABLET | Resolved | 2017-04-20 | 2017-10-11 | 7494 |
| PMS-ROSUVASTATIN | 20MG | TABLET | Resolved | 2017-04-20 | 2018-02-20 | 7497 |
| PMS-ROSUVASTATIN | 20MG | TABLET | Resolved | 2017-04-20 | 2018-04-19 | 7500 |
| PMS-ROSUVASTATIN | 10MG | TABLET | Resolved | 2017-05-04 | 2017-07-25 | 8955 |
| PMS-ROSUVASTATIN | 20MG | TABLET | Resolved | 2017-05-04 | 2017-11-09 | 8958 |
| PMS-ROSUVASTATIN | 5MG | TABLET | Resolved | 2017-05-04 | 2018-02-20 | 8961 |
| PMS-ROSUVASTATIN | 10MG | TABLET | Resolved | 2017-05-11 | 2017-10-11 | 10112 |
| PMS-ROSUVASTATIN | 5MG | TABLET | Resolved | 2017-05-11 | 2018-02-12 | 10115 |
| PMS-ROSUVASTATIN | 40MG | TABLET | Resolved | 2017-07-11 | 2018-01-26 | 15144 |
| PMS-ROSUVASTATIN | 40MG | TABLET | Resolved | 2017-08-11 | 2018-01-26 | 18890 |
| PMS-ROSUVASTATIN | 5MG | TABLET | Resolved | 2017-08-11 | 2018-01-26 | 18893 |
| PMS-ROSUVASTATIN | 10MG | TABLET | Resolved | 2017-10-27 | 2018-05-18 | 27359 |
| PMS-ROSUVASTATIN | 40MG | TABLET | Resolved | 2018-05-04 | 2018-06-07 | 48563 |
| PMS-ROSUVASTATIN | 20MG | TABLET | Resolved | 2018-05-18 | 2018-06-29 | 49753 |
| PMS-ROSUVASTATIN | 10MG | TABLET | Resolved | 2019-06-28 | 2019-07-31 | 87992 |
| PMS-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-28 | 2019-07-31 | 87995 |
| PMS-SALBUTAMOL | 0.5MG | SOLUTION | Resolved | 2017-04-07 | 2017-07-25 | 6152 |
| PMS-SALBUTAMOL | 2MG | SOLUTION | Resolved | 2018-02-12 | 2018-06-07 | 39555 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-DILTIAZEM CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Discontinued | 2020-06-17 | 2020-06-17 | 118096 |
| PMS-DOCUSATE SODIUM | 20MG | SYRUP | Discontinued | 2020-06-15 | 2021-10-27 | 117714 |
| PMS-DOCUSATE SODIUM | 250MG | SYRUP | Discontinued | 2020-06-15 | 2021-10-27 | 117730 |
| PMS-DOCUSATE SODIUM | 20MG | SYRUP | Discontinued | 2021-06-21 | 2021-06-21 | 141302 |
| PMS-DOCUSATE SODIUM | 20MG | SYRUP | Discontinued | 2021-11-16 | 2021-11-16 | 149365 |
| PMS-DOCUSATE SODIUM DROPS 10MG/ML | 10MG | DROPS DROPS | Discontinued | 2020-06-15 | 2021-10-27 | 117733 |
| PMS-DOMPERIDONE | 10MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117760 |
| PMS-DORZOLAMIDE-TIMOLOL | 20MG 5MG | SOLUTION | Discontinued | 2020-06-16 | 2020-06-16 | 118026 |
| PMS-DUTASTERIDE | 0.5MG | CAPSULE | Discontinued | 2022-12-09 | 2022-12-09 | 177691 |
| PMS-DUTASTERIDE | 0.5MG | CAPSULE | Discontinued | 2022-12-09 | 2022-12-09 | 177694 |
| PMS-ELETRIPTAN | 20MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117933 |
| PMS-ELETRIPTAN | 40MG | TABLET | Discontinued | 2020-06-17 | 2020-06-17 | 118162 |
| PMS-ELETRIPTAN | 40MG | TABLET | Discontinued | 2020-06-17 | 2020-06-17 | 118165 |
| PMS-ENALAPRIL | 16MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6041 |
| PMS-ENALAPRIL | 4MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6044 |
| PMS-ENALAPRIL | 4MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6047 |
| PMS-EPIRUBICIN | 2MG | SOLUTION | Discontinued | 2019-06-28 | 2019-06-28 | 87934 |
| PMS-EPIRUBICIN | 2MG | SOLUTION | Discontinued | 2019-06-28 | 2019-06-28 | 87938 |
| PMS-EPIRUBICIN | 2MG | SOLUTION | Discontinued | 2021-11-16 | 2021-11-16 | 149400 |
| PMS-EPIRUBICIN | 2MG | SOLUTION | Discontinued | 2021-11-16 | 2021-11-16 | 149403 |